- Home
- IPSC vs MLSS Comparison
IPSC vs MLSS Comparison
Compare IPSC & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- MLSS
- Stock Information
- Founded
- IPSC 2019
- MLSS 1989
- Country
- IPSC United States
- MLSS United States
- Employees
- IPSC N/A
- MLSS N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- MLSS Industrial Specialties
- Sector
- IPSC Health Care
- MLSS Health Care
- Exchange
- IPSC Nasdaq
- MLSS Nasdaq
- Market Cap
- IPSC 43.6M
- MLSS 42.4M
- IPO Year
- IPSC 2021
- MLSS 1995
- Fundamental
- Price
- IPSC $0.50
- MLSS $0.59
- Analyst Decision
- IPSC Strong Buy
- MLSS Buy
- Analyst Count
- IPSC 5
- MLSS 1
- Target Price
- IPSC $3.33
- MLSS $1.25
- AVG Volume (30 Days)
- IPSC 603.4K
- MLSS 57.3K
- Earning Date
- IPSC 11-04-2025
- MLSS 11-13-2025
- Dividend Yield
- IPSC N/A
- MLSS N/A
- EPS Growth
- IPSC N/A
- MLSS N/A
- EPS
- IPSC N/A
- MLSS N/A
- Revenue
- IPSC $114,128,000.00
- MLSS $9,083,205.00
- Revenue This Year
- IPSC $1,589.94
- MLSS $17.24
- Revenue Next Year
- IPSC N/A
- MLSS $14.58
- P/E Ratio
- IPSC N/A
- MLSS N/A
- Revenue Growth
- IPSC 5491.77
- MLSS 7.84
- 52 Week Low
- IPSC $0.34
- MLSS $0.38
- 52 Week High
- IPSC $1.86
- MLSS $1.39
- Technical
- Relative Strength Index (RSI)
- IPSC 43.47
- MLSS 46.41
- Support Level
- IPSC $0.46
- MLSS $0.55
- Resistance Level
- IPSC $0.52
- MLSS $0.65
- Average True Range (ATR)
- IPSC 0.03
- MLSS 0.04
- MACD
- IPSC 0.00
- MLSS -0.00
- Stochastic Oscillator
- IPSC 41.33
- MLSS 38.90
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.